A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules

Project: Other project

Project Details

StatusActive
Effective start/end date6/2/206/1/22

Funding

  • Biodesix: $7,175.00